Manzouri Leila, Salehi Rasoul, Shariatpanahi Shervin, Rezaie Parisa
Assistant Professor of Community Medicine, Department of Community Medicine, School of Medicine, Yasuj University of Medical Science, Yasuj, Iran.
Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Science, Isfahan, Iran.
Adv Biomed Res. 2014 Jan 27;3:75. doi: 10.4103/2277-9175.125873. eCollection 2014.
Human papilloma virus (HPV) DNA has been detected in breast carcinoma by different laboratorial techniques, suggesting that the virus could play a role in the pathogenesis of this tumor.
It was a descriptive study. Systematic random sampling was used for selecting 55 cases of breast cancer and 51 controls of benign breast lesions from the file of Seyedshohada hospital of Isfahan since 2005-2009. A total of 106 paraffin-embedded specimens were selected and HPV DNA was analyzed by polymerase chain reaction and sequenced for different types of HPV in case of positivity for HPV DNA. Data analysis was performed by SPSS 16 software using descriptive statistic, Chi-square, and Fisher's exact tests.
Out of 55 malignant and 51 benign breast specimens, 18.2% (10) and 13.7% (7) were positive to HPV DNA, respectively (P = 0.53); 70% (7) malignant and 43% (3) benign breast specimens were positive to high-risk HPV genotypes. In malignant specimens, the most common high- and low-risk genotypes were HPV-16 (3.6%) and HPV-11 (3.6%), respectively. In benign specimens, the most common high- and low-risk genotypes were HPV-31 (3.9%) and HPV-43 (3.9%), respectively. Among malignant and benign specimens, ductal carcinoma and fibro adenoma were the most common lesions positive to different types of HPV, respectively.
This study demonstrated the presence of HPV genome in both malignant and benign tumor tissues in women with breast lesions in Isfahan; therefore, further larger epidemiologic studies need to be analyzed to establish the exact role of this virus in the pathogenesis of breast cancer.
已通过不同实验室技术在乳腺癌中检测到人乳头瘤病毒(HPV)DNA,这表明该病毒可能在这种肿瘤的发病机制中起作用。
这是一项描述性研究。采用系统随机抽样方法,从伊斯法罕赛义德肖哈达医院2005年至2009年的档案中选取55例乳腺癌病例和51例良性乳腺病变对照。共选取106个石蜡包埋标本,通过聚合酶链反应分析HPV DNA,若HPV DNA呈阳性,则对不同类型的HPV进行测序。使用SPSS 16软件进行数据分析,采用描述性统计、卡方检验和费舍尔精确检验。
在55例恶性乳腺标本和51例良性乳腺标本中,HPV DNA阳性率分别为18.2%(10例)和13.7%(7例)(P = 0.53);70%(7例)恶性乳腺标本和43%(3例)良性乳腺标本对高危HPV基因型呈阳性。在恶性标本中,最常见的高危和低危基因型分别为HPV - 16(3.6%)和HPV - 11(3.6%)。在良性标本中,最常见的高危和低危基因型分别为HPV - 31(3.9%)和HPV - 43(3.9%)。在恶性和良性标本中,导管癌和纤维腺瘤分别是对不同类型HPV呈阳性的最常见病变。
本研究表明在伊斯法罕有乳腺病变的女性中,恶性和良性肿瘤组织中均存在HPV基因组;因此,需要进一步进行更大规模的流行病学研究,以确定该病毒在乳腺癌发病机制中的确切作用。